• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, COSTA RICA LTDA (SH) EPIC SUPRA VALVE W/FLEXFIT; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, COSTA RICA LTDA (SH) EPIC SUPRA VALVE W/FLEXFIT; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number ESP100-19
Device Problems Backflow (1064); Calcified (1077); Material Split, Cut or Torn (4008)
Patient Problems Aortic Regurgitation (1716); Calcium Deposits/Calcification (1758)
Event Date 11/30/2020
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
On (b)(6) 2016, a 19mm epic supra valve w/flexfit was implanted in the patient's aortic position with the non-everting mattress suture technique using pledgets due to calcification.Severe calcification was confirmed on the annulus, and annular enlargement was performed also.An abbott sizer was used in the surgery.Severe aortic regurgitation was confirmed near the stent and the commissure on the echocardiogram which led to a re-do avr.The epic supra valve was explanted on (b)(6) 2020, replaced with a 19mm freestyle aortic valve(manufacturer: medtronic).Upon explant, tears were confirmed on the ncc and the lcc leaflets.The patient is in stable condition postoperatively.It was reported that the implant was performed by another surgeon at the hospital who has already retired, and therefore, the cause is unknown.The explant surgeon thinks the issue was due to both the valve and the implant procedure technique.
 
Manufacturer Narrative
Explant was reported due to aortic regurgitation.The investigation found that cusps 1 and 3 contained tears.These cusps were thin at the base.Degenerative changes were present in all three cusps.No inflammation or significant calcification were present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.In the absence of any calcification or evidence for infection, the reported event is consistent with a non-calcific leaflet tear.A non-calcific leaflet tear is a form of structural valve deterioration (svd), which is a well-known complication from valve replacement surgery.A non-calcific leaflet tear is commonly attributed to increased operational leaflet stress but may also be related to biological factors which result in tissue degeneration characterized by loss of collagen.In this case, histological evaluation did demonstrate loss of collagen at the tear site, which could have contributed to the formation of the tear.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC SUPRA VALVE W/FLEXFIT
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, COSTA RICA LTDA (SH)
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 01897 -405
CS  01897-4050
MDR Report Key11076045
MDR Text Key223709263
Report Number3008452825-2020-00705
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Replace
Type of Report Initial,Followup
Report Date 02/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/29/2019
Device Model NumberESP100-19
Device Lot Number5169630
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/14/2021
Was the Report Sent to FDA? No
Date Manufacturer Received02/12/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
-
-